Week in Review
Ariad Pharmaceuticals Inc. raised $224 million in a public stock offering.
Cell Therapeutics Inc. is raising $20 million in a registered direct offering of stock and warrants.
Cerulean Pharma Inc. closed a $15 million Series D financing.
Ember Therapeutics raised $34 million in Series A financing for obesity and diabetes drugs.
ImmusanT Inc. raised $20 million in a Series A round for celiac disease vaccine Nexvax2.
Suite: 1100 | Atlanta, Georgia 30346, USA
Tel: +1 877.857.2477
Outside of the US
Tel. +44 203 684 1796
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter